Stock HUM HUMANA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
305.9 USD -1.77% Intraday chart for Humana Inc. -6.83% -33.18%
Apr. 26 Deutsche Bank Adjusts Price Target on Humana to $341 From $355 MT
Apr. 26 HCA beats first-quarter profit estimates on higher patient admissions RE

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 48,537 54,296 59,622 64,843 56,361 36,861 - -
Enterprise Value (EV) 1 50,149 56,283 68,722 70,908 63,323 42,183 40,722 41,028
P/E ratio 18.2 x 16.2 x 20.5 x 23.2 x 22.9 x 20.3 x 15.5 x 12.4 x
Yield 0.6% 0.61% 0.59% 0.62% - 1.22% 1.31% 1.39%
Capitalization / Revenue 0.75 x 0.7 x 0.72 x 0.7 x 0.53 x 0.32 x 0.32 x 0.3 x
EV / Revenue 0.77 x 0.73 x 0.83 x 0.76 x 0.6 x 0.37 x 0.35 x 0.34 x
EV / EBITDA 13.6 x 13.3 x 21.5 x 13.8 x 11.1 x 10.7 x 8.78 x 7.71 x
EV / FCF 11 x 12 x 72.6 x 20.5 x 21.3 x 21.9 x 13 x 11.2 x
FCF Yield 9.07% 8.31% 1.38% 4.89% 4.7% 4.57% 7.71% 8.92%
Price to Book 4.02 x 3.85 x 3.73 x 4.18 x 3.44 x 2.33 x 2.16 x 1.97 x
Nbr of stocks (in thousands) 132,426 132,341 128,534 126,600 123,111 120,501 - -
Reference price 2 366.5 410.3 463.9 512.2 457.8 305.9 305.9 305.9
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 64,888 77,155 83,064 92,870 106,374 113,937 116,103 121,710
EBITDA 1 3,697 4,240 3,201 5,122 5,711 3,945 4,636 5,319
EBIT 1 3,262 3,751 2,488 4,413 4,999 3,176 3,997 4,544
Operating Margin 5.03% 4.86% 3% 4.75% 4.7% 2.79% 3.44% 3.73%
Earnings before Tax (EBT) 1 3,456 4,600 3,354 3,568 3,383 2,449 3,162 3,820
Net income 1 2,707 3,367 2,933 2,806 2,489 1,794 2,326 2,823
Net margin 4.17% 4.36% 3.53% 3.02% 2.34% 1.57% 2% 2.32%
EPS 2 20.10 25.31 22.67 22.08 20.00 15.07 19.69 24.73
Free Cash Flow 1 4,548 4,675 946 3,467 2,977 1,927 3,139 3,660
FCF margin 7.01% 6.06% 1.14% 3.73% 2.8% 1.69% 2.7% 3.01%
FCF Conversion (EBITDA) 123.02% 110.26% 29.55% 67.69% 52.13% 48.85% 67.72% 68.8%
FCF Conversion (Net income) 168.01% 138.85% 32.25% 123.56% 119.61% 107.44% 134.98% 129.63%
Dividend per Share 2 2.200 2.500 2.725 3.150 - 3.745 4.006 4.263
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 21,054 23,970 23,662 22,799 22,439 26,742 26,747 26,423 26,462 29,611 28,343 27,930 27,938 30,171 29,033
EBITDA 1 434 1,604 1,501 1,200 640 1,875 1,854 1,459 508 1,639 1,237 983.9 272.4 1,458 1,398
EBIT 1 240 1,415 1,313 1,018 458 1,657 1,530 1,258 322 1,397 1,062 798.2 83.34 1,308 1,214
Operating Margin 1.14% 5.9% 5.55% 4.47% 2.04% 6.2% 5.72% 4.76% 1.22% 4.72% 3.75% 2.86% 0.3% 4.33% 4.18%
Earnings before Tax (EBT) 1 -60 1,220 1,122 1,297 -71 1,614 1,262 1,098 -591 1,014 845.9 705.5 -161.3 1,245 1,123
Net income 1 -14 930 696 1,195 -15 1,239 959 832 -541 741 687.9 480.8 -139.8 896.3 821.1
Net margin -0.07% 3.88% 2.94% 5.24% -0.07% 4.63% 3.59% 3.15% -2.04% 2.5% 2.43% 1.72% -0.5% 2.97% 2.83%
EPS 2 -0.1100 7.290 5.480 9.390 -0.1200 9.870 7.660 6.710 -4.420 6.110 5.687 3.992 -1.159 7.474 6.876
Dividend per Share 2 0.7000 0.7875 0.7875 0.7875 0.7875 0.8850 0.8850 - - - 0.9800 0.9800 0.9800 1.007 1.023
Announcement Date 2/2/22 4/27/22 7/27/22 11/2/22 2/1/23 4/26/23 8/2/23 11/1/23 1/25/24 4/24/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,612 1,987 9,100 6,065 6,962 5,322 3,861 4,167
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.436 x 0.4686 x 2.843 x 1.184 x 1.219 x 1.349 x 0.8328 x 0.7834 x
Free Cash Flow 1 4,548 4,675 946 3,467 2,977 1,927 3,139 3,660
ROE (net income / shareholders' equity) 21.7% 19.4% 17.9% 20.4% 20.6% 12.5% 14.9% 17.1%
ROA (Net income/ Total Assets) 8.84% 12.8% 7.39% 6.42% 7.21% 3.9% 4.83% 5.57%
Assets 1 30,633 26,224 39,664 43,706 34,544 45,938 48,160 50,723
Book Value Per Share 2 91.10 107.0 124.0 123.0 133.0 131.0 142.0 156.0
Cash Flow per Share 2 39.20 42.40 17.50 36.10 32.00 21.70 32.00 41.00
Capex 1 736 964 1,316 1,120 1,004 860 900 980
Capex / Sales 1.13% 1.25% 1.58% 1.21% 0.94% 0.75% 0.77% 0.8%
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Humana Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
305.9 USD
Average target price
375.4 USD
Spread / Average Target
+22.72%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

1st Jan change Capi.
HUMANA INC. Stock Humana Inc.
-33.18% 36.86B
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+13.93% 125B
CIGNA Stock Cigna
+18.37% 101B
CENTENE CORPORATION Stock Centene Corporation
-0.28% 39.69B
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-5.28% 20.05B
PROGYNY, INC. Stock Progyny, Inc.
-13.82% 3.08B
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-39.49% 993M
CLOVER HEALTH INVESTMENTS, CORP. Stock Clover Health Investments, Corp.
-28.58% 337M
Other Managed Healthcare
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. Financials Humana Inc.